Next, we investigated whether long-term treatment with INT-767 can prevent metabolic disorders in Apoe−/− mice, which can develop all the features of diet-induced metabolic disorders, including obesity, NAFLD, and atherosclerosis. The gene discussed is APOE; the disease is metabolic dysfunction-associated steatotic liver disease.